Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • louis7781x
    Member
    • Oct 2010
    • 74

    #1

    Does CNV-Seq run with DNA-seq or RNA-seq?

    Hi,

    Does anyone has experience to use CNV-seq to detect copy number variation?

    I want to know that CNV-Seq run with DNA-seq or RNA-seq?

    Because I have RNA-seq of tumor paired-end from illumina ,can I use it to run CNV-seq?

    Thanks!!
  • arcolombo698
    Senior Member
    • Nov 2013
    • 142

    #2
    the manual says both. read their paper it is on page 1

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      If a CNV affects an entire gene then you will never be able to detect it with RNAseq. Further, even if it affects only a part of a gene your ability to detect it in tumor-normal pairs is near zero. Their paper says nothing about using RNA for CNV detection (in fact, the word "RNA" only appears once in the paper and only in the context of mentioning other uses of high-throughput sequencing).

      Comment

      • arcolombo698
        Senior Member
        • Nov 2013
        • 142

        #4
        I stand corrected. thank you.

        RNAseq uses cDNA, not quite the same as DNA from Whole Genome.

        Basically there are two types of data used for CNV analysis WGS (whole genome DNA sequencing) and WES (whole exome sequencing data)

        CNV-seq uses WGS that uses Read Depth basis which uses statistical models estimating window lengths. This is in contrast to model based algorithms which use Hidden Markov models, Mean Shift Based models...or paired end mapping to calculate CNVs/SNVs.

        so the answer is : WGS or WES is used. not RNAseq. thank you

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:35 AM
        0 responses
        7 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...